Cancer

• FDA approval · 2012-11-28
  FDA Approved: FLUDEOXYGLUCOSE F18 — Supplemental Application (THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH)

  FDA has approved a supplemental application for Fludeoxyglucose F-18, a PET radiopharmaceutical, reflecting an update to its labeling and/or…

• FDA approval · 2012-08-29
  FDA Approved: GRANIX — Original Application (Cephalon, LLC)

  FDA approved Granix (tbo-filgrastim) through an original Biologics License Application filed by Cephalon, LLC.

• FDA approval · 2011-02-25
  FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (PETNET Solutions, Inc.)

  The FDA approved an original application for Fludeoxyglucose F-18 (FDG F-18) as a radiopharmaceutical for PET imaging, submitted by PETNET S…

• FDA approval · 2008-04-16
  FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)

  The FDA approved a supplemental application for NEULASTA (pegfilgrastim) by Amgen, Inc., approving changes to the drug’s labeling and/or ind…

• FDA approval · 2006-12-21
  FDA Approved: FLUDEOXYGLUCOSE F18 — Supplemental Application (THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH)

  FDA approved a supplemental application for Fludeoxyglucose F18, a PET imaging radiopharmaceutical, expanding its regulatory status.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-10-25
  FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)

  The FDA approved a supplemental application for NEULASTA (pegfilgrastim) submitted by Amgen.